CMC and Process Development for novel Biotherapeutics

At bespark*bio, we deliver bespoke bioprocess development services that solve CMC challenges across the lifecycle of novel biotherapeutics.

We combine proven process building blocks with data modeling and machine learning to reduce lab work, increase accuracy, and accelerate development. Our holistic approach integrates cutting-edge technologies, QbD principles, and practical execution to design efficient, robust, and scalable processes — tailored to each product’s needs.

Our services include:

• CMC strategy development
• Upstream and downstream process development, optimization & characterization
• Analytical method development
• CMC support (e.g., tech transfer, CDMO scouting & oversight)

Whether it’s early-stage development or late-clinical refinement, we enable therapy developers to move faster, reduce risk, and reach manufacturing readiness with confidence.